Upregulation of lung chemokines associated with hemorrhage is reversed with a small molecule multiple selectin inhibitor

Journal of the American College of Surgeons

Volumn 189, Issue 6, 1999, Pages 546-553

  Ramos Kelly, Jaime R ^a   Toledo Pereyra, Luis H ^a   Jordan, Jacqueline A ^c   Rivera Chavez, Fernando A ^a   Dixon, Richard A F ^b   Ward, Peter A ^c  

^a Borgess Research Institute   (United States)

^b TEXAS BIOTECHNOLOGY CORPORATION   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BIMOSIAMOSE; CHEMOKINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MYELOPEROXIDASE; SELECTIN; SELECTIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HEMORRHAGIC SHOCK; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; INTRAVENOUS DRUG ADMINISTRATION; LUNG FLUID; LUNG VENTILATION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; REHYDRATION; TREATMENT OUTCOME;

ANIMALS; BIPHENYL COMPOUNDS; DOWN-REGULATION; LUNG; MALE; MANNOSIDES; NEUTROPHILS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; SELECTINS; SHOCK, HEMORRHAGIC; UP-REGULATION;

EID: 0032726520     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(99)00213-6     Document Type: Article

References (27)

1. Marzi I, Bauer M, Secchi A, et al. Time course and pattern of hepatic leukocyte-endorhelial interaction after hemorrhagic shock in the rat. Circ Shock 1992;37:15.
2. Marzi I, Bauer C, Hower R, et al. Leukocyte-endothelial cell interaction in the liver after hemorrhagic shock in the rat. Circ Shock 1993;40:105-114.
3. Bauer C, Marzi I, Bauer M, et al. Interleukin-1 receptor antagonist attenuates leukocyte-endothelial interactions in the liver after hemorrhagic shock in the rat. Crit Care Med 1995;23:1099-1105.
4. Bauer C, Siaplaouras S, Soule HR, et al. A natural glycoprotein inhibitor (NIF) of CD11b/CD18 reduces leukocyte adhesion in the liver after hemorrhagic shock. Shock 1995;4:187-192.
5. Lasky LA. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 1992;258:964-969.
6. McEver RP. Leukocyte-endothelial cell interactions. Curr Opin Cell Biol 1992;4:840-849.
7. Bevilacqua MR Nelson RM. Selectins. J Clin Invest 1993;91: 379-387.
8. Springer TA. Traffic signals for leukocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314.
9. Tedder TF, Steeber DA, Chen A, et al. The selectins: vascular adhesion molecules. FASEB J 1995;9:866-873.
10. Winn RK, Mihelicic D, Vedder NB, et al. Monoclonal antibodies to leukocyte and endothelial adhesion molecules attenuate ischemia-reperfusion injury. Behring Inst Mitt 1993;92:229-237.
11. Winn RK, Vedder NB, Mihelcic LC, et al. The role of adhesion molecules in reperfusion injury. Agents Actions 1993;41:113-126.
12. Rivera-Chavez FA, Toledo-Pereyra LH, Nora DT, et al. P-selectin blockade is beneficial after uncontrolled hemorrhagic shock. J Trauma 1998;45:3-7.
13. Rivera-Chavez FA, Toledo-Pereyra LH, Nora DT, et al. Dual blockade of selectins improves liver function after hemorrhagic shock. Owen H Wangensteen Surgical Forum 1998;49:84-87.
14. Anaya-Prado R, Toledo-Pereyra LH, Collins JT, et al. Dual blockade of P-selectin and β2-integrin in the liver inflammatory response after uncontrolled hemorrhagic shock. J Am Coll Surg 1998;187:22-31.
15. Capone AC, Safar P, Stezoski W, et al. Improved outcome with fluid restriction in treatment of uncontrolled hemorrhagic shock. J Am Coll Surg 1995;180:49-56.
16. Kogan TP, Dupre B, Beck PJ, et al. Rational design and synthesis of small molecule, nonoligosaccharide selectin inhibitor: (α-D mannopyranosylixy) byphenyl-substituted carboxylk acids. J Med Chem 1995;38:4976-4984.
17. Palma-Vargas JM, Toledo-Pereyra LH, Dean RE, et al. Small-molecule selectin inhibitor protects against liver inflammatory response after ischemia and reperfusion. J Am Coll Surg 1997; 185:365-372.
18. Schierwagen C, Bylund-Fellenius AC, Lundberg C. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharm Meth 1990;23: 179-186.
19. Shanley TP, Schmal H, Warner RL, et al. Requirements for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex induced lung injury. J Immunol 1997;158:3439-3448.
20. Barroso-Aranda J, Schmil-Schonbein GW, Zweifach BW, et al. Granulocytes and no-reflow phenomenon in irreversible hemorrhagic shock. Circ Res 1998;63:437-447.
21. Smith SM, Holm-Rutili MA, Perry MB, et al. Role of neutrophils in hemorrhagic shock-induced gastric mucosal injury in the rat. Gastroenterology 1987;93:466-471.
22. Hammerschmidt DE, Redl H, Schlag G. Quantifying pulmonary leukostasis in hypovolemic/traumatic shock. Acta Chir Scand 1984;31:113-117.
23. Barroso-Aranda J, Schmidt-Schonbein GW. Transformation of neutrophils as indicator of irreversibility in hemorrhagic shock. Am J Physiol 1989;257:H846-H852.
24. Kushimoto S, Okajima K, Uchiba M, et al. Pulmonary vascular injury induced by hemorrhagic shock is mediated by P-selectin. Thromb Res 1996;82:97-106.
25. Peitzman A, Billiar T, Harbrecht B, et al. Hemorrhagic shock. Curr Probl Surg 1995;32:927-1002.
26. Winn RK, Paulson JC, Harlam JM. A monoclonal antibody to P-selectin ameliorates injury associated with hemorrhagic shock in rabbits. Am J Physiol 1994;267:2391-2397.
27. Haljamae H. Organ specific metabolic changes in shock. In: Bond RF, Adams HR, Chaudry IH, eds. Perspectives in shock research. New York: Alan R Liss; 1988:17-26.